Novartis Gets Counterclaims Cut From Heart Drug Patent MDL
By Jasmin Boyce · September 28, 2022, 5:02 PM EDT
A Delaware federal judge has thrown out declaratory judgment counterclaims lodged against Novartis by two generic-drug makers in multidistrict patent litigation over Novartis' heart medication Entresto, determining that the court lacks...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login